Search Results - "Müller, Stefan P."

Cabozantinib in Progressive Medullary Thyroid Cancer by Elisei, Rossella, Schlumberger, Martin J, Müller, Stefan P, Schöffski, Patrick, Brose, Marcia S, Shah, Manisha H, Licitra, Lisa, Jarzab, Barbara, Medvedev, Viktor, Kreissl, Michael C, Niederle, Bruno, Cohen, Ezra E W, Wirth, Lori J, Ali, Haythem, Hessel, Colin, Yaron, Yifah, Ball, Douglas, Nelkin, Barry, Sherman, Steven I

“…Cabozantinib, a tyrosine kinase inhibitor (TKI) of hepatocyte growth factor receptor (MET), vascular endothelial growth factor receptor 2, and rearranged…”
Get full text

Improved Regional Activity Quantitation in Nuclear Medicine Using a New Approach to Correct for Tissue Partial Volume and Spillover Effects by Moore, S. C., Southekal, S., Mi-Ae Park, McQuaid, S. J., Kijewski, M. F., Muller, S. P.

“…We have developed a neσw method of compensating for effects of partial volume and spillover in dual-modality imaging. The approach requires segmentation of…”
Get full text

Identification and Tumour-Binding Properties of a Peptide with High Affinity to the Disialoganglioside GD2 by Müller, Jan, Reichel, Robin, Vogt, Sebastian, Müller, Stefan P, Sauerwein, Wolfgang, Brandau, Wolfgang, Eggert, Angelika, Schramm, Alexander

“…Neuroectodermal tumours are characterized by aberrant processing of disialogangliosides concomitant with high expression of GD2 or GD3 on cell surfaces…”
Get full text

Impact of complete surgical resection on outcome in aggressive non‐Hodgkin lymphoma treated with immunochemotherapy by Schmitz, Christine, Rekowski, Jan, Müller, Stefan P., Farsijani, Navid, Hertenstein, Bernd, Franzius, Christiane, Verschuer, Ulla, La Rosée, Paul, Freesmeyer, Martin, Wilop, Stefan, Krohn, Thomas, Raghavachar, Aruna, Ganser, Arnold, Bengel, Frank M., Prange‐Krex, Gabriele, Kroschinsky, Frank, Kotzerke, Jörg, Giagounidis, Aristoteles, Dührsen, Ulrich, Hüttmann, Andreas

“…Background Surgical resection is considered to be of purely diagnostic value in aggressive lymphoma. Evidence for an impact on outcome is scant and restricted…”
Get full text

Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial by Schmitz, Christine, Hüttmann, Andreas, Müller, Stefan P., Hanoun, Maher, Boellaard, Ronald, Brinkmann, Marcus, Jöckel, Karl-Heinz, Dührsen, Ulrich, Rekowski, Jan

“…Valid prognostic tools are needed to guide risk-adjusted treatment approaches in patients with diffuse large B-cell lymphoma (DLBCL). We assessed total…”
Get full text

Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUVmax Method by Rekowski, Jan, Hüttmann, Andreas, Schmitz, Christine, Müller, Stefan P, Kurch, Lars, Kotzerke, Jörg, Franzius, Christiane, Weckesser, Matthias, Bengel, Frank M, Freesmeyer, Martin, Hertel, Andreas, Krohn, Thomas, Holzinger, Jens, Brink, Ingo, Haberkorn, Uwe, Nyuyki, Fonyuy, van Assema, Daniëlle ME, Geworski, Lilli, Hasenclever, Dirk, Jöckel, Karl-Heinz, Dührsen, Ulrich

“…The value of interim 18F-FDG PET/CT (iPET)–guided treatment decisions in patients with diffuse large B-cell lymphoma (DLBCL) has been the subject of much…”
Get full text

Corrigendum to ‘Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial’ [Eur J Canc 124 (January 2020) 25–36] by Schmitz, Christine, Hüttmann, Andreas, Müller, Stefan P., Hanoun, Maher, Boellaard, Ronald, Brinkmann, Marcus, Jöckel, Karl-Heinz, Dührsen, Ulrich, Rekowski, Jan

Get full text

Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trial by Broecker-Preuss, Martina, Becher-Boveleth, Nina, Müller, Stefan P., Hüttmann, Andreas, Hanoun, Christine, Grafe, Hong, Richter, Julia, Klapper, Wolfram, Rekowski, Jan, Bockisch, Andreas, Dührsen, Ulrich

“…Background [ 18 F]Fluoro-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is the standard imaging procedure in diffuse large B-cell…”
Get full text

Metabolic tumor volume, cancer cell fraction, and prognosis - the case of T-cell/histiocyte-rich large B-cell lymphoma by Schmitz, Christine, Rekowski, Jan, Reinke, Sarah, Müller, Stefan P., Hüttmann, Andreas, Klapper, Wolfram, Dührsen, Ulrich

“…T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) is a rare aggressive lymphoma characterized by a paucity of neoplastic B-cells and a majority of…”
Get full text

Lymphocyte Function at Baseline Could Be a New Predictor of Tumor Burden following Six Cycles of Radium-223 Therapy in Patients with Metastasized, Castration-Resistant Prostate Cancer by Barsegian, Vahé, Möckel, Daniel, Buehler, Sebastian, Müller, Stefan P, Kreissl, Michael C, Ostheim, Patrick, Horn, Peter A, Lindemann, Monika

“…Previous data indicate that one cycle of treatment with radium-223 ( Ra) did not significantly impair lymphocyte function in patients with metastasized,…”
Get full text

Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUV max Method by Rekowski, Jan, Hüttmann, Andreas, Schmitz, Christine, Müller, Stefan P, Kurch, Lars, Kotzerke, Jörg, Franzius, Christiane, Weckesser, Matthias, Bengel, Frank M, Freesmeyer, Martin, Hertel, Andreas, Krohn, Thomas, Holzinger, Jens, Brink, Ingo, Haberkorn, Uwe, Nyuyki, Fonyuy, van Assema, Daniëlle M E, Geworski, Lilli, Hasenclever, Dirk, Jöckel, Karl-Heinz, Dührsen, Ulrich

“…The value of interim F-FDG PET/CT (iPET)-guided treatment decisions in patients with diffuse large B-cell lymphoma (DLBCL) has been the subject of much debate…”
Get full text

Lymphocyte function following radium-223 therapy in patients with metastasized, castration-resistant prostate cancer by Barsegian, Vahé, Müller, Stefan P., Möckel, Daniel, Horn, Peter A., Bockisch, Andreas, Lindemann, Monika

“…Purpose Therapy with the alpha-emitter radium-223 chloride ( 223 Ra) is an innovative therapeutic option in patients with metastasized, castration-resistant…”
Get full text

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial by Hüttmann, Andreas, Rekowski, Jan, Müller, Stefan P., Hertenstein, Bernd, Franzius, Christiane, Mesters, Rolf, Weckesser, Matthias, Kroschinsky, Frank, Kotzerke, Jörg, Ganser, Arnold, Bengel, Frank M., La Rosée, Paul, Freesmeyer, Martin, Höffkes, Heinz-Gert, Hertel, Andreas, Behringer, Dirk, Prange-Krex, Gabriele, Griesshammer, Martin, Holzinger, Jens, Wilop, Stefan, Krohn, Thomas, Raghavachar, Aruna, Maschmeyer, Georg, Brink, Ingo, Schroers, Roland, Gaska, Tobias, Bernhard, Helga, Giagounidis, Aristoteles, Schütte, Jochen, Dienst, Ariane, Hautzel, Hubertus, Naumann, Ralph, Klein, Alfred, Hahn, Dennis, Pöpperl, Gabriele, Grube, Matthias, Marienhagen, Jörg, Schwarzer, Andreas, Kurch, Lars, Höhler, Thomas, Steiniger, Heike, Nückel, Holger, Südhoff, Thomas, Römer, Wolfgang, Brinkmann, Marcus, Ose, Claudia, Alashkar, Ferras, Schmitz, Christine, Dürig, Jan, Hoelzer, Dieter, Jöckel, Karl-Heinz, Klapper, Wolfram, Dührsen, Ulrich

“…Standard first-line treatment of aggressive B cell lymphoma comprises six or eight cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP)…”
Get full text

MR-based attenuation correction for torso-PET/MR imaging: pitfalls in mapping MR to CT data by Beyer, Thomas, Weigert, Markus, Quick, Harald H., Pietrzyk, Uwe, Vogt, Florian, Palm, Christoph, Antoch, Gerald, Müller, Stefan P., Bockisch, Andreas

“…Purpose MR-based attenuation correction (AC) will become an integral part of combined PET/MR systems. Here, we propose a toolbox to validate MR-AC of clinical…”
Get full text

Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial by Schmitz, Christine, Rekowski, Jan, Müller, Stefan P., Hertenstein, Bernd, Franzius, Christiane, Ganser, Arnold, Bengel, Frank M., Kroschinsky, Frank, Kotzerke, Jörg, La Rosée, Paul, Freesmeyer, Martin, Hoeffkes, Heinz‐Gert, Hertel, Andreas, Behringer, Dirk, Mesters, Rolf, Weckesser, Matthias, Mahlmann, Stefan, Haberkorn, Uwe, Martens, Uwe, Prange‐Krex, Gabriele, Brenner, Winfried, Giagounidis, Aristoteles, Moeller, Regina, Runde, Volker, Sandmann, Matthias, Hautzel, Hubertus, Wilop, Stefan, Krohn, Thomas, Dürk, Heinz, Heike, Michael, Alashkar, Ferras, Brinkmann, Marcus, Trenn, Guido, Wacker, Dietmar, Kreisel‐Büstgens, Christiane, Bernhard, Helga, Heil, Gerhard, Larisch, Rolf, Kurch, Lars, Jöckel, Karl‐Heinz, Hoelzer, Dieter, Klapper, Wolfram, Boellaard, Ronald, Dührsen, Ulrich, Hüttmann, Andreas

“…The prospective randomized Positron Emission Tomography (PET)‐Guided Therapy of Aggressive Non‐Hodgkin Lymphomas (PETAL) trial was designed to test the ability…”
Get full text

Performance of a high-sensitivity dedicated cardiac SPECT scanner for striatal uptake quantification in the brain based on analysis of projection data by Park, Mi-Ae, Moore, Stephen C., Müller, Stefan P., McQuaid, Sarah J., Kijewski, Marie Foley

“…Purpose: The authors have previously reported the advantages of high-sensitivity single-photon emission computed tomography (SPECT) systems for imaging…”
Get full text

Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determination by Schmitz, Christine, Hüttmann, Andreas, Müller, Stefan P., Hanoun, Maher, Boellaard, Ronald, Brinkmann, Marcus, Jöckel, Karl-Heinz, Dührsen, Ulrich, Rekowski, Jan

“…Total metabolic tumor volume (TMTV) was measured in 510 patients with DLBCL participating in the PETAL trial. The present data provide information about the…”
Get full text

Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer by Freudenberg, Lutz S, Frilling, Andrea, Kühl, Hilmar, Müller, Stefan P, Jentzen, Walter, Bockisch, Andreas, Antoch, Gerald

“…The usefulness of combined 2-[18F] fluoro-2-deoxy-D: -glucose positron emission tomography and computed tomography (FDG-PET/CT) in locating suspected…”
Get full text

Involvement of the human cerebellum during habituation of the acoustic startle response: A PET study by Timmann, Dagmar, Musso, Christina, Kolb, Florian P, Rijntjes, Michel, Jüptner, Markus, Müller, Stefan P, Diener, Hans Christoph, Weiller, Cornelius

“…The present study investigated the involvement of the human cerebellum in the habituation of the acoustic startle response using PET. The startle response was…”
Get full text

Positron emission tomography/computed tomography--imaging protocols, artifacts, and pitfalls by Bockisch, Andreas, Beyer, Thomas, Antoch, Gerald, Freudenberg, Lutz S, Kühl, Hilmar, Debatin, Jörg F, Müller, Stefan P

“…There has been a longstanding interest in fused images of anatomical information, such as that provided by computed tomography (CT) or magnetic resonance…”
Get more information